US26818M1080
US26818M1080
Dyne Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 468.184.000 | 343.886.000 | 36.1% | |
| Operating Income | -468.184.000 | -343.886.000 | 36.1% |
| Pretax Income | -446.214.000 | -317.418.000 | 40.6% |
| Net Income Common Stockholders | -446.214.000 | -317.418.000 | 40.6% |
| -- | -- | -- | |
| -- | -- | -- |